1348 related articles for article (PubMed ID: 26171115)
41. Advanced Mitochondrial Respiration Assay for Evaluation of Mitochondrial Dysfunction in Alzheimer's Disease.
Grimm A; Schmitt K; Eckert A
Methods Mol Biol; 2016; 1303():171-83. PubMed ID: 26235066
[TBL] [Abstract][Full Text] [Related]
42. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
43. Autophagy and Tau Protein.
Hamano T; Enomoto S; Shirafuji N; Ikawa M; Yamamura O; Yen SH; Nakamoto Y
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299093
[TBL] [Abstract][Full Text] [Related]
44. Oxidative Stress Occurs Prior to Amyloid Aβ Plaque Formation and Tau Phosphorylation in Alzheimer's Disease: Role of Glutathione and Metal Ions.
Roy RG; Mandal PK; Maroon JC
ACS Chem Neurosci; 2023 Sep; 14(17):2944-2954. PubMed ID: 37561556
[TBL] [Abstract][Full Text] [Related]
45. Calcium dysregulation in Alzheimer's disease.
Bojarski L; Herms J; Kuznicki J
Neurochem Int; 2008; 52(4-5):621-33. PubMed ID: 18035450
[TBL] [Abstract][Full Text] [Related]
46. Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease.
Boche D; Donald J; Love S; Harris S; Neal JW; Holmes C; Nicoll JA
Acta Neuropathol; 2010 Jul; 120(1):13-20. PubMed ID: 20532897
[TBL] [Abstract][Full Text] [Related]
47. GSK-3 and Tau: A Key Duet in Alzheimer's Disease.
Sayas CL; Ávila J
Cells; 2021 Mar; 10(4):. PubMed ID: 33804962
[TBL] [Abstract][Full Text] [Related]
48. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy.
Cente M; Filipcik P; Pevalova M; Novak M
Eur J Neurosci; 2006 Aug; 24(4):1085-90. PubMed ID: 16930434
[TBL] [Abstract][Full Text] [Related]
49. Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?
Alavi Naini SM; Soussi-Yanicostas N
Oxid Med Cell Longev; 2015; 2015():151979. PubMed ID: 26576216
[TBL] [Abstract][Full Text] [Related]
50. Impaired transcription in Alzheimer's disease: key role in mitochondrial dysfunction and oxidative stress.
Caldeira GL; Ferreira IL; Rego AC
J Alzheimers Dis; 2013; 34(1):115-31. PubMed ID: 23364141
[TBL] [Abstract][Full Text] [Related]
51. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
[TBL] [Abstract][Full Text] [Related]
52. Pathological Impacts of Chronic Hypoxia on Alzheimer's Disease.
Zhang F; Niu L; Li S; Le W
ACS Chem Neurosci; 2019 Feb; 10(2):902-909. PubMed ID: 30412668
[TBL] [Abstract][Full Text] [Related]
53. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
Thal DR; Attems J; Ewers M
J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
[TBL] [Abstract][Full Text] [Related]
54. New age of neuroproteomics in Alzheimer's disease research.
Kovacech B; Zilka N; Novak M
Cell Mol Neurobiol; 2009 Sep; 29(6-7):799-805. PubMed ID: 19225878
[TBL] [Abstract][Full Text] [Related]
55. Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology.
Lopes JP; Blurton-Jones M; Yamasaki TR; Agostinho P; LaFerla FM
J Alzheimers Dis; 2009; 16(3):541-9. PubMed ID: 19276549
[TBL] [Abstract][Full Text] [Related]
56. Role of RAGE in Alzheimer's Disease.
Cai Z; Liu N; Wang C; Qin B; Zhou Y; Xiao M; Chang L; Yan LJ; Zhao B
Cell Mol Neurobiol; 2016 May; 36(4):483-95. PubMed ID: 26175217
[TBL] [Abstract][Full Text] [Related]
57. The role of tau oligomers in the onset of Alzheimer's disease neuropathology.
Cárdenas-Aguayo Mdel C; Gómez-Virgilio L; DeRosa S; Meraz-Ríos MA
ACS Chem Neurosci; 2014 Dec; 5(12):1178-91. PubMed ID: 25268947
[TBL] [Abstract][Full Text] [Related]
58. Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer's Disease.
Cioffi F; Adam RHI; Broersen K
J Alzheimers Dis; 2019; 72(4):981-1017. PubMed ID: 31744008
[TBL] [Abstract][Full Text] [Related]
59. Senescence may mediate conversion of tau phosphorylation-induced apoptotic escape to neurodegeneration.
Wang JZ; Wang ZH
Exp Gerontol; 2015 Aug; 68():82-6. PubMed ID: 25777063
[TBL] [Abstract][Full Text] [Related]
60. Autophagic dysfunction in Alzheimer's disease: Cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis.
Uddin MS; Mamun AA; Labu ZK; Hidalgo-Lanussa O; Barreto GE; Ashraf GM
J Cell Physiol; 2019 Jun; 234(6):8094-8112. PubMed ID: 30362531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
